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ABSTRACT
Sufficient glucose availability is crucial for exploiting 
the genetic potential of milk production during early 
lactation, and endocrine changes are mainly related to 
repartitioning of nutrient supplies toward the mam-
mary gland. Long-chain fatty acids, such as essential 
fatty acids (EFA) and conjugated linoleic acid (CLA), 
have the potential to improve negative energy balance 
and modify endocrine changes. In the present study, 
the hypothesis that combined CLA and EFA treatment 
supports glucose metabolism around the time of calv-
ing and stimulates insulin action and the somatotropic 
axis in cows in an additive manner was tested. Rumen-
cannulated German Holstein cows (n = 40) were inves-
tigated from wk 9 antepartum (AP) until wk 9 post-
partum (PP). The cows were abomasally supplemented 
with coconut oil (CTRL, 76 g/d); 78 g/d of linseed and 
4 g/d of safflower oil (EFA); Lutalin (CLA, isomers 
cis-9,trans-11 and trans-10,cis-12 CLA, each 10 g/d); 
or the combination of EFA+CLA. Blood samples were 
collected several times AP and PP to determine the 
concentrations of plasma metabolites and hormones re-
lated to glucose metabolism and the somatotropic axis. 
Liver tissue samples were collected several days AP and 
PP to measure glycogen concentration and the mRNA 
abundance of genes related to gluconeogenesis and the 
somatotropic axis. On d 28 AP and 21 PP, endogenous 
glucose production (eGP) and glucose oxidation (GOx) 
were measured via tracer technique. The concentration 
of plasma glucose was higher in CLA than in non-
CLA-treated cows, and the plasma β-hydroxybutyrate 
concentration was higher in EFA than in non-EFA cows 
on d 21 PP. The eGP increased from AP to PP with el-
evated eGP in EFA and decreased eGP in CLA-treated 
cows; GOx was lower in CLA than in CTRL on d 21 
PP. The plasma insulin concentration decreased after 
calving in all groups and was higher in CLA than in 
non-CLA cows at several time points. Plasma glucagon 
and cortisol concentrations on d 21 PP were lower in 
CLA than non-CLA groups. The glucagon/insulin and 
glucose/insulin ratios were higher in CTRL than in 
CLA group during the transition period. Plasma IGF-I 
concentration was lower in EFA than non-EFA cows 
on d 42 AP and was higher during the dry period and 
early lactation in CLA than in non-CLA cows. The IGF 
binding protein (IGFBP)-3/-2 ratio in blood plasma 
was higher in CLA than in non-CLA cows. Hepatic 
glycogen concentration on d 28 PP was higher, but the 
mRNA abundance of PC and IGFBP2 was lower in 
CLA than non-CLA cows on d 1 PP. The EFA treat-
ment decreased the mRNA abundance of IGFBP3 AP 
and PCK1, PCK2, G6PC, PCCA, HMGCS2, IGFBP2, 
and INSR at several time points PP. Results indicated 
elevated concentrations of plasma glucose and insulin 
along with the stimulation of the somatotropic axis in 
cows treated with CLA, whereas EFA treatment stimu-
lated eGP but not mRNA abundance related to eGP 
PP. The systemic effects of the combined EFA+CLA 
treatment were very similar to those of CLA treatment, 
but the effects on hepatic gene expression partially cor-
responded to those of EFA treatment.
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INTRODUCTION
The time period from late gestation to early lactation 
involves substantial metabolic and endocrine changes in 
dairy cows that are related to the repartitioning of the 
nutrient supply for milk production (Bauman, 2000; 
Drackley et al., 2001; Gross and Bruckmaier, 2019). 
Providing sufficient glucose is an important prerequi-
site for exploiting the genetic potential for milk synthe-
sis (Bauman, 2000; Drackley et al., 2001). Glucose is 
needed for the synthesis of lactose, which is the major 
osmoregulator of mammary water uptake, and conse-
quently, milk volume (Linzell, 1972), as well as milk fat 
synthesis (Grummer and Carroll, 1991). Postcalving, 
glucose metabolism adapts by increasing endogenous 
glucose production (eGP) and decreasing peripheral 
glucose utilization in tissues other than the mammary 
gland (Drackley et al., 2001; Aschenbach et al., 2010; 
Hammon et al., 2016). There are marked changes in 
the hepatic gene expression of enzymes related to glu-
coneogenesis that reflect the increased glucose demands 
and changes in substrate availability associated with 
the onset of lactation (Aschenbach et al., 2010; Donkin, 
2016; Hammon et al., 2016). The endocrine regulation 
of nutrition partitioning during the transition period 
and the glucose supply for milk synthesis involve insu-
lin action and the somatotropic axis (Bauman, 2000; 
Drackley et al., 2001; Lucy, 2004). Insulin sensitivity is 
decreased, and the growth hormone (GH)-IGF-I axis is 
uncoupled during early lactation to favor the mobiliza-
tion of body energy reserves and the provision of sub-
strates such as glucose for milk production (Etherton 
and Bauman, 1998; Drackley et al., 2001; De Koster 
and Opsomer, 2013).
The feeding of various fatty acids (FA) can relieve 
the energy load in dairy cows during early lactation. 
The supplementation of trans-10,cis-12 CLA causes 
milk fat depression, which has the potential to improve 
the energy balance in early lactation (Baumgard et 
al., 2000; Odens et al., 2007). The CLA supplementa-
tion leads to nutrient repartitioning toward increased 
lactose release and decreased eGP, resulting in a 
glucose-sparing effect during early lactation (Hötger et 
al., 2013). Interestingly, trans-10,cis-12 CLA causes an 
insulin-resistant state in rodent and human (Riserus et 
al., 2002; Halade et al., 2010; Bezan et al., 2018). The 
effects of CLA treatment on endocrine changes associ-
ated with nutrient partitioning and the gene expression 
of gluconeogenic enzymes in the liver of dairy cows are 
less clear. In addition, common rations for dairy cows 
contain high levels of corn silage in the TMR, providing 
forage with a high energy density but low amounts of 
fat and essential fatty acids (EFA) with a high n-6/n-3 
FA ratio (Chilliard et al., 2001; Barkema et al., 2015). 
Interestingly, n-3 FA supplementation improves insulin 
sensitivity in mice and in cattle (Pires and Grummer, 
2008; Fortin et al., 2010; Fan et al., 2020). The gene 
expression of enzymes related to gluconeogenesis seems 
to be under the control of long-chain FA (White et 
al., 2011), and n-3 FA stimulate whole-body glycogen 
storage (Clarke, 2001).
The aim of the present study was to investigate the 
effect of combined CLA and EFA supplementation on 
glucose metabolism and the regulation of nutrition par-
titioning by the somatotropic axis in dairy cows during 
late gestation and early lactation. Previous findings 
within this project confirmed the improvement of the 
energy balance around the time of calving in cows asso-
ciated with combined CLA and EFA supplementation 
(Vogel et al., 2020). Therefore, the tested hypothesis 
was that CLA and EFA treatments during the transi-
tion from late pregnancy to early lactation affect glu-
cose metabolism and stimulate insulin action and the 
somatotropic axis, respectively, and that the combined 
EFA and CLA treatment may support these endocrine 
changes in an additive manner.
MATERIALS AND METHODS
Animals, Husbandry, Fatty Acid  
Supplementation, and Feeding
All experimental procedures were carried out in 
compliance with the German Animal Welfare Act and 
were approved by the animal ethics committee of the 
state of Mecklenburg-Western Pomerania, Germany 
(Landesamt für Landwirtschaft, Lebensmittelsicher-
heit und Fischerei Mecklenburg-Vorpommern; LALLF 
M-V/TSD/7221.3–1-038/15).
A detailed description of the study design, feeding 
management, and diet composition was published re-
cently (Vogel et al., 2020). Briefly, from December 2015 
to September 2017, German Holstein cows (n = 40) 
were investigated in 5 blocks consisting of 8 cows (2 cows 
per group; 2 cows were removed from the evaluation 
because of premature calving). The German Holstein 
cows were purchased from a local farm (Agrarprodukte 
Dedelow GmbH, Prenzlau, Germany) in approximately 
wk 18 of gestation during their second lactation and 
were kept in a freestall barn at the Leibniz Institute for 
Farm Animal Biology (FBN), Dummerstorf, Germany. 
Before the beginning of the trial, the cows were surgi-
cally fitted with rumen cannulas (#2C or #1C 4 in; 
Bar Diamond Inc., Parma, ID) as described previously 
(Haubold et al., 2020; Vogel et al., 2020). The cows 
were assigned to 4 supplementation groups exhibiting 
comparable projected milk production, BW, and calv-
ing interval. The cows were supplemented daily from 63 
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d antepartum (AP) until slaughter on d 63 postpartum 
(PP) with 1 of the 4 following treatments: 76 g/d of co-
conut oil (CTRL, n = 9; Bio-Kokosöl #665, Kräuter-
haus Sanct Bernhard KG, Bad Ditzenbach, Germany); 
78 g/d of linseed plus 4 g/d of safflower oil (EFA, 
n = 9; linseed oil, DERBY Leinöl #4026921003087, 
DERBY Spezialfutter GmbH, Münster, Germany; 
safflower oil, GEFRO Distelöl, GEFRO Reformver-
sand Frommlet KG, Memmingen, Germany; linseed/
safflower oil ratio = 19.5:1; n-6/n-3 FA ratio = 1:3); 
38 g/d of Lutalin (CLA, n = 10; 27.2% cis-9,trans-11 
and 27.0% trans-10,cis-12 CLA in Lutalin, BASF SE, 
Ludwigshafen, Germany); or 120 g/d of the mixture 
of linseed and safflower oil plus Lutalin in the same 
mentioned quantities (EFA+CLA, n = 10). During 
the dry period, each dose was halved. The amounts and 
FA composition of the daily infused supplements, which 
are shown in Supplemental Tables S1 and S2 (https: / 
/ doi .org/ 10 .22000/ 358), were recently evaluated in a 
companion dose-response study in mid-lactating dairy 
cows (Haubold et al., 2020). The treatments were ab-
omasally infused twice a day (2 equal portions) at 0700 
and 1630 h via infusion lines using 60-mL catheter tip 
syringes. All supplements were liquefied by heating to 
38°C to allow infusion. The placement of the abomasal 
infusion line was confirmed weekly by palpation. Ob-
servations and sampling were performed from wk 10 
before calving until wk 9 during the third lactation. At 
40 ± 6 d AP (mean ± SD), the cows were dried off, and 
from 10 d before until 1 d after parturition, the cows 
were housed in straw-bedded calving boxes. The cows 
were slaughtered on d 63 ± 3 PP (mean ± SD).
The cows were fed a corn silage-based TMR during 
late and early lactation (wk 22–6 AP and wk 1–9 PP) 
and during the dry period (wk 6–1 AP). We recently 
published the details of the feed sampling procedure 
and analyses in a companion paper (Vogel et al., 2020). 
The ingredients and chemical composition of the diets 
are shown Table 1. The major FA concentrations in the 
diets are shown in Supplemental Table S3 (https: / / doi 
.org/ 10 .22000/ 358). The diets were provided ad libitum 
beginning at 0600 h, and the cows had free access to 
water as well as trace-mineralized salt blocks. After 
calving, a calcium bolus (RUMINCaDL, Wirtschafts-
genossenschaft Deutscher Tierärzte eG; Garbsen, Ger-
many) and 300 mL/d 1,2-propanediol (Propylenglykol 
USP; Dr. Pieper Technologie- und Produktentwicklung 
GmbH, Wuthenow, Germany) were administered in-
traruminally on 3 consecutive days. Individual daily 
feed intake was recorded as the disappearance of feed 
from troughs connected to an electronic scale, to 
which access was controlled by individual transponders 
(Institute for Agricultural Engineering and Animal 
Husbandry ILT, Bavarian State Research Center for 
Agriculture LfL, Freising, Germany). The cows were 
milked twice daily at 0630 and 1800 h, and the milk 
yield was recorded electronically.
Blood and Liver Tissue Sampling and Analyses
A detailed description of the sampling procedures 
was published in a companion paper (Vogel et al., 
2020). Blood samples were collected 63, 42, 35, 28, 21, 
and 10 d before expected calving, 1 d after calving, and 
then once weekly up to d 56 immediately after morning 
milking and before feeding via jugular vein puncture 
using a VACUETTE system (Greiner Bio-One Inter-
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Table 1. Ingredients and chemical composition of the diets
Item, g/kg of DM
Diet
Lactation Dry period1
Ingredient   
 Corn silage 457 421
 Straw 97 223
 Compound feed DEFA2 (granulated) 446 —
 Dried sugar beet pulp — 163
 Extracted soybean meal — 99
 Rye grain — 75
 Minerals and vitamins3 — 10
 Urea4 — 9
Chemical composition5   
 NEL, MJ/kg of DM 7.1 6.5
 Crude fat 23 21
 Crude fiber 173 219
 CP 146 141
 Utilizable protein 143 141
 NFC 432 379
 NDF 346 423
 ADF 197 249
 RNB 0.5 0.0
1The dry period diet was fed from wk 6 to 1 before calving. The actual 
dry period started 40 ± 6 d before birth.
2Ceravis AG, Malchin, Germany. Ingredients: 46.5% dried sugar beet 
pulp, 25.3% extracted soybean meal, 23.8% grain of rye, 1.4% urea, 
1.1% premix cow, 1.00% calcium, 0.37% phosphorus, 0.42% sodium, 
vitamins A, D3, E, copper, ferric, zinc, manganese, cobalt, iodine, se-
lenium. Chemical composition: 44.4% NFC, 24.1% CP, 21.6% NDF, 
12.4% ADF, 9.3% crude fiber, 8.2% crude ash, 1.8% crude fat, and 7.9 
MJ of NEL/kg of DM.
3Concentrations of minerals and vitamins (KULMIN MFV Plus, 
Bergophor Futtermittelfabrik Dr. Berger GmbH & Co., KG, Kulmbach, 
Germany): 8.5% magnesium, 7.5% phosphorus, 6.5% sodium, 3.5% 
HCl-insoluble ash, 1.5% calcium; vitamins and trace minerals per kg: 
1,000,000 IU of vitamin A, 200,000 IU of vitamin D3, 10,000 mg of 
vitamin E, 180 mg of vitamin B1, 90 mg of vitamin B2, 90 mg of vi-
tamin B6, 200 mg of vitamin B5, 2,500 mg of vitamin B3, 675 mg of 
vitamin B12, 12 mg of vitamin B9, 100 mg of vitamin H, 2,500 mg of 
zinc, 3,500 mg of manganese, 500 mg of copper, 20 mg of cobalt, 75 mg 
of iodine, 30 mg of selenium as sodium selenite, and 15 mg of Se from 
Saccharomyces cerevisiae.
4Piarumin (SKW Stickstoffwerke Piesteritz GmbH, Lutherstadt 
Wittenberg, Germany): 99% urea, 46.5% total nitrogen.
5NEL, utilizable protein, and ruminal nitrogen balance (RNB) = 
German Society of Nutrition Physiology (2001, 2008, 2009) and 
Deutsche Landwirtschaftliche Gesellschaft (DLG, 2013).
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national GmbH, Kremsmünster, Austria) containing 
either K3EDTA (1.8 g/L) for the analysis of hormones 
of the somatotropic axis or sodium fluoride (2–4 g/L) 
in combination with potassium oxalate (1–3 g/L) as 
an anticoagulant for the measurement of plasma me-
tabolites. Immediately after collection, the samples 
were cooled on crushed ice and centrifuged at 1,500 × 
g (4°C, 20 min). The supernatant was harvested and 
stored at −20°C until analysis.
Plasma metabolites were analyzed using an auto-
matic spectrophotometer (ABX Pentra 400; HORIBA 
ABX SAS, Montpellier, France) and specific kits for 
glucose (#A11A01667, hexokinase–glucose-6-phosphate 
dehydrogenase method; HORIBA ABX SAS, Montpel-
lier, France) and BHB (#RB 1008, 3-hydroxybutyrate 
dehydrogenase method; Randox Laboratories Ltd., 
Crumlin, UK). The interassay variations were <4% 
for glucose and <5% for BHB when testing for control 
plasma with low, medium, and high concentrations. 
The concentrations of plasma insulin (#RIA-1257) and 
glucagon (#RIA-1258) were determined via RIA using 
kits from DRG Instruments GmbH (Marburg, Ger-
many) adapted for cattle (Hammon et al., 2009). The 
intra- and interassay coefficients of variation were 3.7 
and 5.5% for insulin and 4.6 and 13.4% for glucagon. 
Plasma cortisol concentrations were analyzed using a 
commercially available ELISA kit (#EIA1887; DRG 
Instruments GmbH, Marburg, Germany) according to 
the manufacturer’s instructions. The assay was vali-
dated for use with bovine plasma (Weber et al., 2013b). 
The test sensitivity was 3.5 ng/mL, and the intra- and 
interassay coefficients of variation were 4.7 and 12.7%, 
respectively. Plasma growth hormone (GH) and IGF-
I were measured by radioimmunoassay as described 
previously (Vicari et al., 2008). Intra- and interassay 
coefficients of variation for GH and IGF-I RIA were be-
low 10 and 15%, respectively. Concentrations of plasma 
IGFBP were analyzed via quantitative Western ligand 
blot analysis as previously described using plasma 
samples containing K3EDTA (Wirthgen et al., 2016). 
The intra- and interassay coefficients of variation were 
<15% and <20.0% for all IGFBP, respectively.
Liver biopsy samples were obtained after morning 
milking by needle biopsy under local anesthesia on d 
63 and 21 before calving and d 1 and 28 PP by us-
ing a tailor-made biopsy needle (length 400 mm; outer 
diameter of 6 mm; Weber et al., 2013b). Additional 
samples were collected during slaughter on d 63 PP. 
Liver samples were immediately frozen in liquid nitro-
gen and stored at −80°C until analysis. Liver tissue was 
ground in liquid nitrogen, and glycogen content was 
determined using a commercial photometric kit based 
on the amyloglucosidase-catalyzed release of glucose 
(ENZYTEC Starch #E1268, R-Biopharm AG, Darm-
stadt, Germany).
For gene expression analysis, liver tissue was homog-
enized using a FastPrep 120 centrifuge (Thermo Elec-
tron Corporation, Waltham, MA), and total RNA was 
isolated from the liver samples with TRIzol Reagent 
(Life Technologies, Darmstadt, Germany), cleaned with 
an RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany), 
and transcribed into cDNA as described by Hammon 
et al. (2009). The integrity, quantity, and quality of 
total RNA were confirmed according to Haubold et al. 
(2020). The mean RNA integrity number for liver tissue 
was 6 ± 1. The quantity and purity of the total RNA 
were assessed on the basis of optical density measure-
ments, and the A260: 280 ratio ranged from 1.8 to 2.0. 
The relative mRNA abundance of genes related to glu-
cose metabolism and the somatotropic axis was quanti-
fied as described by Saremi et al. (2012). The primer 
sequences and PCR conditions used for the reference 
genes low-density lipoprotein 10 (LRP10) and RNA 
polymerase II (POLR2A) and the target genes related 
to glucose metabolism and the somatotropic axis are 
reported in Supplemental Table S4 (https: / / doi .org/ 10 
.22000/ 358). The selected targets were genes encoding 
enzymes involved in glucose metabolism, such as py-
ruvate carboxylase (PC), cytosolic and mitochondrial 
phosphoenolpyruvate carboxykinase (cytosolic PCK1; 
mitochondrial PCK2), glucose-6-phosphatase (G6PC), 
and propionyl-CoA-carboxylase α (PCCA), or ketogen-
esis, such as 3-hydroxy-3-methyl-glutaryl-CoA synthase 
2 (HMGCS2). Additionally, genes encoding hormones 
or receptors involved in the somatotropic axis, such as 
GH receptor 1A (GHR1A), IGF-I (IGF1), insulin recep-
tor (INSR), and IGFBP-2 and −3 (IGFBP2; IGFBP3), 
were investigated. The primer products were verified 
by sequencing with the BigDye Terminator v1.1 Cycle 
Sequencing Kit and an ABI 3130 Genetic Analyzer 
(Thermo Fisher Scientific Inc., Waltham, MA).
The mRNA expression relative to reference genes 
was performed by real-time reverse-transcription PCR 
with the use of a LightCycler 96 (Roche Diagnostics 
GmbH, Mannheim, Germany); SYBR Green I was used 
as the fluorescent dye. Duplicate measurements were 
performed for all samples, and each block included 2 
negative controls (no cDNA and no RT) and 2 inter-
run calibrators. Melting curve analysis and agarose gel 
electrophoreses were used to confirm the specificity of 
the PCR products. The quantification cycle values and 
amplification efficiencies obtained with LinRegPCR 
version 2017.0 (Ruijter et al., 2013) were imported into 
qBASE+ version 3.1 (Biogazelle, Gent, Belgium) for 
all subsequent calculations and quality controls. The 
geometric mean of the reference gene abundance was 
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applied for normalization. The data are presented as 
the ratio of the copy number of the gene of interest to 
the geometric mean reference gene abundance.
Tracer Studies
On d 28 before expected calving and d 21 PP, eGP 
and glucose oxidation (GOx) were determined after 
feed withdrawal for 12 h via the primed continuous 
intravenous infusion of [U-13C]-glucose [99 atom% 13C, 
Euriso-Top SAS, Staint-Aubin Cedex, France; prime: 
5.38 μmol/kg of BW; infusion: 7.53 μmol/(kg of BW 
× h); dissolved in 0.9% saline] for 4 h (Hammon et al., 
2008; Hötger et al., 2013; Weber et al., 2016). Cows 
were fitted with 2 jugular catheters (Cavafix Certo with 
Splittocan, B. Braun Vet Care GmbH, Tuttlingen, Ger-
many) for tracer infusion and blood sampling. Blood 
samples were collected 30 and 20 min before tracer in-
fusion and at 60, 120, 150, 180, 210, and 240 min after 
the initiation of infusion in tubes containing Li-heparin 
(14–15 IU/mL; S-Monovette, Sarstedt, Nürnberg, 
Germany). The enrichment of [U-13C]-glucose was de-
termined by GC-MS (QP2010, coupled with GC 2010; 
Shimadzu, Duisburg, Germany) to calculate eGP as de-
scribed (Hammon et al., 2008; Steinhoff-Wagner et al., 
2011). Whole blood in K3EDTA tubes collected before 
and at regular intervals between 60 and 240 min after 
the initiation of tracer infusion was used to isolate CO2 
for the measurement of the 13C/12C ratio by isotope 
ratio mass spectrometry and calculate GOx (Hammon 
et al., 2008; Weber et al., 2016).
Additional blood samples were collected hourly until 
6 h after the initiation of tracer infusion to measure 
concentrations of plasma glucose, BHB, insulin, gluca-
gon, cortisol, and GH. Blood samples were treated, and 
measurements were performed as described above.
Statistical Analyses
Statistical analyses were performed with SAS for 
Windows, release 9.4 (SAS Institute Inc., Cary, NC). 
The basal concentrations of plasma metabolites and 
hormones and gene expression in the liver were ana-
lyzed by repeated-measures ANOVA using the MIXED 
procedure and a model including EFA (levels: yes, no), 
CLA (levels: yes, no), time (level: d relative to calv-
ing), block (levels: 1– 5), and the respective interactions 
as fixed effects and the calving interval and projected 
milk yield during the second lactation as covariates. 
Repeated measures of each cow were considered by us-
ing the repeated statement of the MIXED procedure 
with a compound symmetry covariance structure. The 
ranges of the repeated variable time for the metabo-
lite and hormone data were as follows: AP (d 63–10 
AP), the transition period (d 21 AP to 28 PP), PP (d 
1–56 PP), and the entire period (d 63 AP to 56 PP). 
The data were analyzed separately for each observa-
tion period. The liver glycogen concentration and gene 
expression data were analyzed considering only the 
entire period (d 63 AP to 63 PP). The concentrations 
of plasma metabolites and hormones during profiling 
were analyzed by repeated-measures ANOVA using the 
MIXED procedure and a model including EFA (levels: 
yes, no), CLA (levels: yes, no), d (levels: d 28 AP, d 21 
PP), hour (levels: 0–6 h), block (levels: 1–5), and the 
respective interactions as fixed effects as well as the 
calving interval and projected milk yield during the 
second lactation as covariates. Due to large differences 
between d 28 AP and d 21 PP, the data on whole-body 
glucose metabolism determined via the tracer tech-
nique were analyzed separately for d 28 AP and d 21 
PP by ANOVA using the MIXED procedure and with 
a model containing EFA (levels: yes, no), CLA (levels: 
yes, no), block (levels: 1–5), and the respective inter-
actions as fixed effects as well as the calving interval 
and projected milk yield during the second lactation 
as covariates. For the analysis at d 21 PP, milk yield 
on the day of measurement was used as an additional 
covariate. The differences over time between d 28 AP 
and d 21 PP were calculated in a separate model by 
repeated-measures ANOVA. The least squares means 
(LSM) and their standard errors were computed for 
each fixed effect in the ANOVA models to display the 
results. All group differences of these LSM were tested 
using the Tukey-Kramer procedure. The SLICE state-
ment of the MIXED procedure was used to assess the 
partitioned analyses of the LSM for interactions. All 
differences with P < 0.05 were considered significant.
RESULTS
Plasma Glucose and Related Hormones as well  
as Whole-Body Glucose Metabolism
The plasma glucose concentration (Figure 1A) peaked 
(P < 0.001) on d 28 AP, dropped down with calving, and 
slightly increased thereafter (P < 0.001). On d 21 PP, 
plasma glucose concentration indicated a CLA effect 
(P < 0.05) and was 15% higher in CLA-treated than in 
EFA-treated cows (P < 0.05). During the 6-h time pro-
file, plasma glucose concentration remained constant on 
d 28 AP, but on d 21 PP, glucose concentration slightly 
decreased (P < 0.001) with a 17% higher (P < 0.05) 
glucose concentration in EFA+CLA than in EFA after 
5 h and a 11 to 12% higher glucose concentration (P < 
0.05) in CLA than in non-CLA-treated cows 5 and 6 h 
after beginning of the measurement (Figure 1B). The 
plasma BHB concentration (Figure 1C) increased after 
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calving, with an EFA effect on d 21 PP (P < 0.05) and 
a 75% higher concentration (P = 0.05) in EFA+CLA 
than in CTRL. Accordingly, the BHB concentration 
during profiling was lower (P < 0.001) on d 28 AP than 
on d 21 PP and declined (P < 0.001) on d 21 PP in 
CLA and EFA+CLA (Figure 1D). During plasma pro-
filing on d 21, PP BHB concentration was 43% higher 
(P < 0.05) in EFA- than in non-EFA-treated cows, 70% 
higher (P < 0.05) in EFA+CLA than in CTRL at the 
beginning of the profiling, and 80% higher (P < 0.05) 
in EFA+CLA and EFA than in CTRL at 1 h after the 
start.
The plasma insulin concentration increased after dry-
ing off (P < 0.001) and decreased (P < 0.001) markedly 
after calving in all groups (Figure 2A). Plasma insulin 
was 26 to 44% higher (P < 0.05) in CLA treated than 
non-CLA cows from d 21 AP to d 1 PP, as well as on d 
21 PP, and was highest (P < 0.05) on d 1 PP in CLA. 
During profiling, plasma insulin was lower (P < 0.05) 
PP than AP and dropped (P < 0.001) after beginning 
within the first hours AP and PP (Figure 2B). On d 
28 AP, plasma insulin was 24% lower (P < 0.05) at 
the beginning of the profiling in EFA than in non-EFA 
groups, and on d 21 PP was 79% higher (P < 0.05) in 
CLA than in the non-CLA groups at the beginning. In 
addition, there was a trend (P = 0.1) on d 21 PP for 
57% higher plasma insulin in CLA than non-CLA cows 
across all time points. There were no significant differ-
ences over time or treatment effects for basal glucagon 
concentration (Figure 2C). With respect to profiling, 
plasma glucagon concentration increased (P < 0.05) in 
non-CLA cows but decreased (P < 0.05) in CLA from 
d 28 AP to d 21 PP (Figure 2D). On d 21, PP plasma 
glucagon was 21 to 34% lower (P < 0.05) in CLA than 
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Figure 1. Concentrations of plasma glucose (A, B) and BHB (C, D) during the entire study (A, C) and during 6-h metabolic profiling with 
feed withdrawal on d 28 antepartum and d 21 postpartum (B, D) in cows supplemented daily with coconut oil (CTRL; n = 9), linseed and saf-
flower oil (EFA; n = 9), Lutalin (CLA; cis-9,trans-11 and trans-10,cis-12 CLA; n = 10), and EFA+CLA (n = 10) from d 63 antepartum until 
d 56 postpartum. Data are presented as LSM ± SE; LSM with different letters (a, b) differ (P < 0.05) at the respective time point. X = EFA 
effect at the respective time point. Y = CLA effect at the respective time point. Statistically significant (P < 0.05) effects of the basal plasma 
glucose concentration during the antepartum (time), transition (time), and postpartum (time) periods, during the entire study (time), and dur-
ing profiling (day, hour, EFA × day, CLA × day). Statistically significant (P < 0.05) effects for the basal plasma BHB concentration during the 
transition (time) and postpartum (time) periods, during the entire study (time), and during profiling (day, hour, EFA × day).
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in the non-CLA groups from 4 to 6 h and was higher (P 
< 0.05) in EFA than in EFA+CLA and CLA at 4 and 
5 h after the beginning of blood sampling.
The glucagon/insulin and glucose/insulin ratios in-
creased after calving (P < 0.01) in all groups, were 4.5- 
and 3.8-fold higher (P < 0.05) in CTRL than in CLA 
during the transition period (Table 2), and peaked on 
d 21 PP (P < 0.05) in CTRL (data not shown). During 
the profiling studies, the 2 ratios were higher (P < 0.05) 
on d 21 PP than on d 28 AP (data not shown). On d 21 
PP, the glucagon/insulin ratio in all groups except for 
EFA+CLA and the glucose/insulin ratio in EFA and 
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Figure 2. Concentrations of plasma insulin (A, B), glucagon (C, D), and cortisol (E, F) during the entire study (A, C, E) and during 6-h 
metabolic profiling with feed withdrawal on d 28 antepartum and d 21 postpartum (B, D, F) in cows supplemented daily with coconut oil 
(CTRL; n = 9), linseed and safflower oil (EFA; n = 9), Lutalin (CLA; cis-9,trans-11 and trans-10,cis-12 CLA; n = 10), and EFA+CLA (n = 
10) from d 63 antepartum until d 56 postpartum. Data are presented as LSM ± SE; LSM with different letters (a, b) differ (P < 0.05) at the 
respective time point. X = EFA effect at the respective time point. Y = CLA effect at the respective time point. Statistically significant (P < 
0.05) effects for the basal plasma insulin concentration during the antepartum (time), transition (time; CLA), and postpartum (time; CLA) 
periods, during the entire study (time) and during profiling (day, hour, day × hour). Statistically significant (P < 0.05) effects for the plasma 
glucagon concentration during profiling (day, day × hour, CLA × day, CLA × day × hour). Statistically significant (P < 0.05) effects for the 
basal plasma cortisol concentration during the antepartum (time) and transition (time) periods, during the entire study (time), and during 
profiling (CLA, CLA × day, hour; day × hour).
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CLA cows increased (P < 0.05) during blood sampling, 
and both ratios were 77% (glucagon/insulin) and 33% 
(glucose/insulin) lower (P < 0.05) in CLA than in the 
non-CLA groups. The glucagon/insulin ratio on d 21 
PP was higher (P < 0.05) in CTRL than in CLA and 
EFA+CLA and was higher (P < 0.05) in EFA than in 
EFA+CLA (LSM ± SE for CTRL, EFA, CLA, and 
EFA+CLA were 8.46 ± 0.91, 7.27 ± 0.89, 5.11 ± 0.84, 
and 3.76 ± 0.84 mol/mol, respectively). The glucose/
insulin ratio was higher (P < 0.05) in CTRL than in 
EFA+CLA on d 21 PP (LSM ± SE for CTRL, EFA, 
CLA, and EFA+CLA were 681 ± 78, 518 ± 75, 505 ± 
72, and 394 ± 71 mmol/nmol, respectively). The glu-
cose/glucagon ratio decreased (P < 0.05) after calving 
in EFA+CLA but indicated no further time and treat-
ment differences (data not shown). During the profiling 
studies, the glucose/glucagon ratio was higher (P < 
0.05) on d 28 AP than on d 21 PP (data not shown). 
On d 21 PP, the glucose/glucagon ratio was higher (P 
< 0.05) in CLA than in EFA and was higher (P < 0.05) 
in CLA than non-CLA-treated groups (LSM ± SE for 
CTRL, EFA, CLA, and EFA+CLA were 88.7 ± 6.9, 
83.5 ± 6.6, 109.1 ± 6.3, and 98.8 ± 6.2 mmol/nmol, 
respectively).
Plasma cortisol varied AP (P < 0.001) and during 
the transition period (P < 0.05) with peaks (P < 0.05 
or less) at d 28 AP and d 1 after calving but without 
differences between groups (Figure 2E). The 6-h profile 
of the plasma cortisol concentration indicated no dif-
ferences over time between AP and PP, but plasma 
cortisol was 60% lower (P < 0.05) on d 21 PP in CLA 
than in the non-CLA cows, especially 4 and 5 h after 
the beginning of blood sampling (Figure 2F).
The results for eGP and GOx are shown in Table 
3. Endogenous glucose production increased from AP 
to PP (P < 0.001) by 63%, indicating an EFA and 
CLA effect with 6% elevated eGP (P < 0.05) in EFA 
compared with the non-EFA groups and 11% decreased 
eGP (P < 0.01) in CLA compared with the non-CLA 
groups and was higher (P < 0.05) in EFA than in CLA 
(18%) and EFA+CLA cows (12%) on d 21 PP (P < 
0.05). On the other hand, GOx decreased from d 28 
AP to d 21 PP (P < 0.001) by 130% and was 38% 
lower in CLA cows than in CTRL cows PP (P < 0.05). 
The percentage of GOx relative to eGP declined (P < 
0.001) from d 28 AP to d 21 PP 3.6-foald, indicating an 
EFA × CLA interaction (P = 0.05) on d 21 PP. There 
was a trend (P < 0.1) of a decreased GOx/eGP ratio in 
EFA and CLA compared with CTRL cows.
Somatotropic Axis in Blood Plasma
The growth hormone concentration in blood plasma 
increased during early lactation (P < 0.05) and was 
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49% higher (P < 0.05) in CLA than in non-CLA cows 
on d 49 PP (Figure 3A). The 6-h time profile of plasma 
GH showed only minor changes by d, with slightly 
higher GH concentrations being observed on d 21 PP 
than d 28 AP, especially in EFA (Figure 3B). On d 21 
PP, plasma GH increased (P < 0.05) in EFA+CLA and 
showed a tendency to increase (P < 0.1) in EFA up to 
2 h after the beginning of blood sampling. At 2 h on 
d 21 PP, 87% higher plasma GH was observed in EFA 
than in non-EFA cows, and plasma GH was higher (P 
< 0.05) in EFA+CLA than in CTRL and EFA. The 
plasma IGF-I concentration was highest (P < 0.05) on 
d 35 AP and decreased (P < 0.001) in all groups dur-
ing the transition period until d 14 PP (Figure 3C). 
The plasma IGF-I results indicated an EFA effect (P 
< 0.05) on d 42 AP, with 46% higher concentrations in 
CLA than in EFA cows (P < 0.05). Beginning on d 28 
AP in the CLA group and d 21 AP in the EFA group, 
plasma IGF-I was higher (P < 0.05) than in CTRL 
until calving (25–46% difference). After calving, plasma 
IGF-I was 25 to 37% higher (P < 0.05) at several time 
points in CLA than in non-CLA cows, and at the end 
of the study, plasma IGF-I was higher (P < 0.05) in the 
CLA than in CTRL.
The concentration of plasma IGFBP-2 increased (P 
< 0.05) from the AP to the PP period by 158%, and 
the results indicated a 35 to 43% decreased plasma 
concentration (P < 0.05) with CLA treatment on d 
42 AP and d 56 PP and a lower (P < 0.05) concentra-
tion in the CLA group than in the EFA group on d 56 
PP (Figure 4A). The plasma IGFBP-3 concentration 
decreased (P < 0.001) during AP by 46%, reached the 
lowest concentration on d 1 PP, and slowly increased 
(P < 0.001) thereafter (Figure 4B). Elevated concen-
trations (P < 0.05) were observed on d 42 and 21 AP 
and d 28 and 56 PP in CLA (by 23–34%) and on d 21 
AP in EFA groups (by 23%). Plasma IGFBP-3 was 
higher (P < 0.05) in EFA+CLA than in CTRL on d 21 
AP and higher (P < 0.05) in CLA than in CTRL on d 
28 PP. The concentration of IGFBP-3 was 23% higher 
(P < 0.05) in CLA than in non-CLA cows during the 
transition and PP periods. The IGFBP-3/-2 ratio was 
60 to 170% higher (P < 0.05) in CLA than in CTRL 
and EFA during the entire study, reached the lowest 
point on d 14 PP, and increased (P < 0.001) thereafter 
(Figure 4C). A decreasing effect by 32% (P < 0.05) of 
EFA treatment was observed on d 42 AP. The concen-
tration of plasma IGFBP-4 slightly decreased AP (P < 
0.01) and was higher (P < 0.05) in CLA than in the 
non-CLA groups on d 56 PP by 32% (Figure 4D).
Liver Glycogen Concentration and Gene  
Expression Involved in Glucose Metabolism  
and the Somatotropic Axis
One cow of the CLA group was not included in the 
analyses due to failure to obtain liver samples by biop-
sies. The hepatic glycogen content decreased at calving 
(P < 0.001) by 58% and was 16% higher (P < 0.05) in 
CLA than in non-CLA-treated cows on d 28 PP (Fig-
ure 5A). The abundance of PC mRNA increased (P < 
0.001) 3.7-fold on d 1 PP and was increased up to 100% 
(P < 0.05) in CTRL on d 1, indicating a decreasing ef-
fect (P < 0.05) of EFA and CLA treatment (Figure 5B). 
The PCK1 mRNA abundance was lower (P < 0.05) AP 
than PP and increased 3-fold with ongoing lactation 
(P < 0.001), with 42% lower expression (P < 0.05) 
being observed in EFA than non-EFA-treated cows on 
d 28 PP (Figure 5C). The abundance of PCK2 mRNA 
increased at calving (P < 0.001) by 32%, was lower in 
EFA+CLA than in CTRL (P < 0.05) on d 1 PP and 
was highest (P < 0.05) in CLA on d 28 PP (Figure 5D). 
The abundance of PCK2 mRNA indicated a decreasing 
effect of EFA treatment (P < 0.05) on d 1 and 28 PP by 
37 and 42%, respectively. The abundance of G6PC and 
PCCA mRNA increased (P < 0.01) after d 1 PP by 100 
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Table 3. Endogenous glucose production (eGP) and glucose oxidation (GOx) on d 28 antepartum (AP) and d 21 postpartum (PP) in cows 
supplemented daily with coconut oil (CTRL; n = 9), linseed and safflower oil (EFA; n = 9), CLA (n = 10), or the combination of EFA and CLA 





CTRL EFA CLA EFA+CLA EFA CLA EFA × CLA
eGP, 
mmol/(kg × h)
d 28 AP 0.69 ± 0.03B 0.70 ± 0.02B 0.69 ± 0.02B 0.72 ± 0.02B  0.37 0.56 0.62
d 21 PP 1.14 ± 0.04A,ab 1.23 ± 0.03A,a 1.04 ± 0.03A,b 1.10 ± 0.03A,b  0.05 0.002 0.63
GOx, 
mmol/(kg × h)
d 28 AP 0.37 ± 0.03A 0.32 ± 0.03A 0.36 ± 0.02A 0.37 ± 0.02A  0.58 0.39 0.25
d 21 PP 0.18 ± 0.02B,a 0.15 ± 0.02B,ab 0.13 ± 0.02B,b 0.16 ± 0.02B,ab  0.86 0.19 0.09
GOx, % of eGP 
 
d 28 AP 52.7 ± 2.6A 46.3 ± 2.5A 51.5 ± 2.4A 51.6 ± 2.4A  0.22 0.41 0.19
d 21 PP 16.3 ± 1.6B 12.1 ± 1.4B 12.6 ± 1.4B 14.4 ± 1.4B  0.43 0.63 0.05
A,BMeans of a particular parameter within a column with different uppercase superscripts differ (P < 0.05).
a,bMeans within a row with different lowercase superscripts differ (P < 0.05). 
1Values are presented as LSM ± SE.
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and 133%, respectively (Figure 5E and F). On d 28 PP, 
the abundance of PCCA and G6PC was 58 and 43% 
lower (P < 0.01) in EFA than in the non-EFA groups, 
with higher expression (P < 0.05) being observed in 
CLA than in EFA+CLA (G6PC) or EFA (PCCA). The 
mRNA abundance of HMGCS2 increased 2-fold after 
calving (P < 0.001), was 2-fold higher (P < 0.05) on d 
28 PP in CLA than in EFA+CLA and was decreased 
53% (P < 0.05) by EFA treatment (Figure 5G).
The abundance of GHR1A and IGF1 was lowest 
(P < 0.05) on d 1 PP and increased 3-fold up to d 
63 PP, respectively (Figure 6A, B). The abundance 
of GHR1A showed an increasing tendency (P < 0.1) 
by 75% on d 63 PP in EFA+CLA than in CTRL. 
In addition, GHR1A mRNA showed a tendency to be 
stimulated 78% (P < 0.1) by CLA treatment on d 28 
PP and 36% by EFA on d 63 PP. The abundance of 
IGFBP2 increased 2.5-fold (P < 0.001) from AP to the 
end of the study, with lower expression being observed 
in EFA on d 28 PP (P < 0.01; by 60%) and in CLA (P 
< 0.001) on d 1 and d 63 PP by 56 and 47% (Figure 
6C). The IGFBP2 mRNA abundance was higher (P < 
0.05) on d 28 PP in CLA than in EFA+CLA and was 
higher (P < 0.05) on d 63 PP in EFA than in CLA and 
EFA+CLA. The abundance of IGFBP3 was highest (P 
< 0.001) on d 63 PP and was decreased 49% by EFA 
treatment on d 21 AP (Figure 6D). The abundance of 
INSR mRNA slightly increased (P < 0.001) through-
out the experimental period and was 47 and 63% lower 
(P < 0.05) in EFA than in non-EFA groups on d 1 
and 28 PP (Figure 6E). On d 28 PP, INSR mRNA 
abundance was higher (P < 0.05) in CLA than in EFA 
and EFA+CLA. The INSR mRNA abundance across 
all time points was 52% higher in the CLA (P < 0.05) 
and showed a tendency to be 44% higher in CTRL (P 
= 0.07) than in EFA.
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Figure 3. Concentrations of plasma of growth hormone (GH; A) and IGF-I (C) during the entire study as well as GH (B) during 6-h meta-
bolic profiling with feed withdrawal on d 28 antepartum and d 21 postpartum in cows supplemented daily with coconut oil (CTRL; n = 9), 
linseed and safflower oil (EFA; n = 9), Lutalin (CLA; cis-9,trans-11 and trans-10,cis-12 CLA; n = 10), and EFA+CLA (n = 10) abomasally from 
d 63 antepartum until d 56 postpartum. Data are presented as LSM ± SE; LSM with different letters (a, b, c) differ (P < 0.05) at the respec-
tive time point. X = EFA effect at the respective time point. Y = CLA effect at the respective time point. Statistically significant (P < 0.05) 
effects for the concentration of plasma GH during the antepartum (time), transition (time), and postpartum (time) periods, during the entire 
study (time), and during profiling (day, EFA × day). Statistically significant (P < 0.05) effects for the concentration of plasma IGF-I during 
the antepartum (time; EFA × time; EFA × CLA × time), transition (time; EFA × CLA; EFA × CLA × time), and postpartum (time; CLA) 
periods and during the entire study (time; EFA × time; EFA × CLA × time).
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DISCUSSION
Glucose Metabolism, Endocrine Regulation,  
and Hepatic mRNA Abundance
The metabolic changes in terms of decreased glucose 
and increased BHB concentrations in dairy cows during 
transition followed the expectations resulting from pre-
viously described findings (Hammon et al., 2009, Gross 
et al., 2011a, Weber et al., 2013b). The rates of eGP 
and GOx measured in this study were consistent with 
recently presented data from our group (Hammon et 
al., 2008; Hötger et al., 2013; Weber et al., 2016). The 
increase in eGP on d 21 PP compared with d 28 AP 
ensured an adequate glucose supply to the mammary 
gland for milk production (Aschenbach et al., 2010). 
In addition, whole-body GOx and the ratio of GOx 
to eGP decreased with the onset of lactation, which 
increased the availability of glucose for milk production 
(Drackley et al., 2001).
We observed only minor differences in the basal 
plasma glucose concentration because of EFA supple-
mentation, which was consistent with previous stud-
ies (Zachut et al., 2010; Mach et al., 2013; do Prado 
et al., 2016). Interestingly, the present study revealed 
an elevated concentration of plasma BHB due to EFA 
treatment on d 21 PP in basal blood samples and dur-
ing hourly measurements. Previous investigations of 
the effect of n-3 FA supplementation in dairy cows on 
the plasma BHB concentration showed no changes or 
even decreased plasma BHB in early lactation (Mach et 
al., 2013; do Prado et al., 2016). On d 21 PP, the basal 
plasma glucose concentration and the concentration 
during profiling were lowest in EFA cows. A shortage 
of glucose availability for milk production is associated 
with elevated plasma nonesterified FA (NEFA) and 
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Figure 4. Concentrations of plasma IGF-binding protein 2 (IGFBP-2; A), IGFBP-3 (B), the calculated ratio (IGFBP-3: IGFBP-2; C) and 
IGFBP-4 (D) in cows supplemented daily with coconut oil (CTRL; n = 9), linseed and safflower oil (EFA; n = 9), Lutalin (CLA; cis-9,trans-11 
and trans-10,cis-12 CLA; n = 10), and EFA+CLA (n = 10) abomasally from d 63 antepartum until d 56 postpartum. Data are presented as LSM 
± SE; LSM with different letters (a, b) differ (P < 0.05) at the respective time point. X = EFA effect at the respective time point. Y = CLA 
effect at the respective time point. Statistically significant (P < 0.05) effects for the concentration of plasma IGFBP-2 during the antepartum 
(time), transition (time), and postpartum (time) periods and during the entire study (time). Statistically significant (P < 0.05) effects for the 
concentration of plasma IGFBP-3 during the antepartum (time; EFA × time), transition (time; CLA), and postpartum (time; CLA) periods 
and during the entire study (time; CLA; EFA × time). Statistically significant (P < 0.05) effects for the IGFBP-3/-2 ratio during the antepar-
tum (CLA; CLA × time), transition (time; CLA), and postpartum (time; CLA) periods and during the entire study (time; CLA). Statistically 
significant (P < 0.05) effects for the concentration of plasma IGFBP-4 during the antepartum period (time; EFA × time) and during the entire 
study (time).
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Figure 5. Liver glycogen concentration (A) and relative hepatic mRNA expression of pyruvate carboxylase (PC; B), cytosolic phosphoenol-
pyruvate carboxykinase (PCK1; C), mitochondrial phosphoenolpyruvate carboxykinase (PCK2; D), glucose-6-phosphatase (G6PC; E), mito-
chondrial propionyl-CoA carboxylase α chain (PCCA; F), and hydroxyl-methyl-glutaryl-CoA-synthase 2 (HMGCS2; G) in cows supplemented 
daily with coconut oil (CTRL; n = 9), linseed and safflower oil (EFA; n = 9), Lutalin (CLA; cis-9,trans-11 and trans-10; n = 9), and EFA+CLA 
(n = 10) abomasally from d 63 antepartum until slaughter on d 63 postpartum. Data are presented as LSM ± SE; LSM with different letters 
(a, b) differ (P < 0.05) at the respective time point. X: EFA effect at the respective time point. Y: CLA effect at the respective time point. 
Statistically significant (P < 0.05) effects on the liver glycogen concentration during the entire study (time). Statistically significant (P < 0.05) 
effects for the relative hepatic mRNA expression of PC during the entire study (time; EFA; EFA × time). Statistically significant (P < 0.05) 
effects for the relative hepatic mRNA expression of PCK1 during the entire study (time). Statistically significant (P < 0.05) effects for the rela-
tive hepatic mRNA expression of PCK2 during the entire study (EFA × CLA; time). Statistically significant (P < 0.05) effects for the relative 
hepatic mRNA expression of G6PC during the entire study (time). Statistically significant (P < 0.05) effects for the relative hepatic mRNA 
expression of PCCA during the entire study (time). Statistically significant (P < 0.05) effects for the relative hepatic mRNA expression of 
HMGCS2 during the entire study (time).
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BHB concentrations during early lactation (Drackley et 
al., 2001), and the plasma NEFA concentration on d 21 
PP was high in EFA cows in the present study (Vogel et 
al., 2020). Therefore, the low plasma glucose concentra-
tion may partly explain the elevated BHB concentration 
observed on d 21 PP. However, eGP on d 21 PP was 
highest in the EFA cows, indicating counter-regulation 
to maintain plasma glucose concentration in EFA cows. 
Interestingly, a stimulatory effect of α-linolenic acid 
on eGP, which was the leading FA in the EFA treat-
ment, was observed in bovine hepatocytes (Mashek and 
Grummer, 2003).
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Figure 6. Relative hepatic mRNA expression of growth hormone receptor 1A (GHR1A; A), IGF-I (IGF1; B), IGF-binding protein 2 
(IGFBP2; C), IGF-binding protein 3 (IGFBP3; D), and insulin receptor (INSR; E) in cows supplemented daily with coconut oil (CTRL; n = 9), 
linseed and safflower oil (EFA; n = 9), Lutalin (CLA cis-9,trans-11 and trans-10,cis-12 CLA; n = 9), and EFA+CLA (n = 10) abomasally from 
d 63 antepartum until slaughter on d 63 postpartum. Data are presented as LSM ± SE; LSM with different letters (a, b) differ (P < 0.05) at the 
respective time point. X = EFA effect at the respective time point. Y = CLA effect at the respective time point. Statistically significant (P < 
0.05) effects for the relative hepatic mRNA expression of GHR1A during the entire study (time). Statistically significant (P < 0.05) effects for 
the relative hepatic mRNA expression of IGF1 during the entire study (time). Statistically significant (P < 0.05) effects for the relative hepatic 
mRNA expression of IGFBP2 during the entire study (time; CLA). Statistically significant (P < 0.05) effects for the relative hepatic mRNA 
expression of IGFBP3 during the entire study (time). Statistically significant (P < 0.05) effects for the relative hepatic mRNA expression of 
INSR during the entire study (time; EFA).
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Plasma BHB was not noticeably elevated in the 
CTRL group at the time of calving and thereafter 
when compared with EFA and CLA groups. There is 
evidence in the literature that the medium chain fatty 
acids that are enriched in coconut oil lead to faster 
oxidation and increased plasma ketone bodies such as 
BHB (Dayrit, 2015), which is also seen in calves (Sato, 
1994). The dosage of coconut oil administered was 
probably too low to detect an effect of coconut oil on 
plasma ketone bodies in the present study. We found 
an elevated plasma BHB concentration but a decreased 
plasma NEFA concentration and an improved energy 
balance in EFA+CLA cows (Vogel et al., 2020), which 
does not support the classical concept of an increase in 
the plasma BHB concentration associated with elevated 
plasma NEFA and an overloaded fat concentration in 
the liver during early lactation (Drackley et al., 2001). 
The elevated plasma BHB concentration in EFA+CLA 
was probably a consequence of milk fat depression 
caused by CLA (Bernal-Santos et al., 2003; Urrutia and 
Harvatine, 2017; Vogel et al., 2020), and not increased 
BHB production in the liver. A decreased BHB produc-
tion in liver is supported by the low hepatic mRNA 
abundance of HMGCS2, encoding a key enzyme in 
ketone body synthesis, in EFA+CLA cows on d 28 PP.
Despite the higher plasma glucose concentration ob-
served on d 21 PP, eGP was decreased by CLA treat-
ment. The inverse relationship between plasma glucose 
and eGP supported our previous finding of the effect 
of CLA treatment on plasma glucose and whole-body 
glucose metabolism (Grummer and Carroll, 1991; Höt-
ger et al., 2013). Recently published data of the present 
study indicated a strong milk fat depression during 
early lactation in CLA cows by 50% when compared 
with CTRL and EFA groups. (Vogel et al., 2020). The 
decrease in eGP due to CLA treatment indicated a de-
creased glucose demand for milk fat synthesis induced 
by trans-10,cis-12 CLA (Baumgard et al., 2000), but 
could also result from the more efficient use of metabo-
lizable energy in CLA-treated cows (von Soosten et al., 
2012; Hötger et al., 2013). In this context, it is note-
worthy that cows supplemented only with CLA also 
showed a decrease in GOx and an elevated glucose/
glucagon ratio on d 21 PP in the present study. This 
finding emphasizes less glucose utilization induced by 
CLA treatment.
Endocrine changes during the transition and early 
lactation periods supported the concept of alleviated 
glucose load by decreasing glucose utilization during 
the CLA treatment (Drackley et al., 2001; Reist et al., 
2003; Weber et al., 2013b). An elevated insulin con-
centration in CLA-supplemented cows during the tran-
sition period was previously described (Saremi et al., 
2014, Grossen-Rösti et al., 2018). The increased basal 
plasma insulin concentration and decreased glucagon 
to insulin and glucose to insulin ratios were consistent 
with the diminution of eGP after calving in CLA cows 
(De Koster and Opsomer, 2013; Hammon et al., 2016). 
Plasma cortisol was decreased in CLA groups at the 
end of the profiling on d 21 PP. Cortisol may act as 
a gluconeogenic hormone in cattle (Brockman and 
Laarveld, 1986) and evoke an insulin-resistant state in 
dairy cows (Kusenda et al., 2013; Hammon et al., 2016) 
and young calves (Scheuer et al., 2006). We therefore 
speculate that insulin sensitivity was increased in the 
CLA-treated groups due to decreased cortisol release in 
blood plasma. However, previous studies have not indi-
cated increased insulin sensitivity under CLA treatment 
(Saremi et al., 2014). On the contrary, CLA treatment, 
especially trans-10,cis-12 CLA, caused an insulin-resis-
tant state in rodents, but dosages used in those studies 
were much higher than administered in the present 
study (Halade et al., 2010; Bezan et al., 2018). Further 
studies using insulin-dependent glucose clamps might 
be necessary to clarify this issue, but the fact that eGP 
as well as plasma NEFA and hepatic triglycerides (Vo-
gel et al., 2020) were decreased in CLA-treated cows 
may indicate no insulin-resistant state because of the 
CLA treatment. The elevated glycogen concentrations 
in the liver confirmed the improved glucose and energy 
status of CLA groups (Vogel et al., 2020), because the 
hepatic glycogen concentration is positively associated 
with the energy balance after calving (Hammon et al., 
2009; Weber et al., 2013b). The CLA supplementation 
did not affect the hepatic glycogen concentration dur-
ing the transition period in previous studies, but the 
energy balance was also not affected by CLA treatment 
in these studies (Bernal-Santos et al., 2003; Hötger et 
al., 2013).
The temporal pattern of gluconeogenic enzyme 
mRNA abundance in the liver during the transition 
period was consistent with previously reviewed changes 
and was the consequence of an increased demand for 
glucose and a shift in gluconeogenic substrate availabil-
ity after calving (Greenfield et al., 2000; Donkin, 2016, 
Hammon et al., 2016). The higher abundance of PC 
mRNA as well PCK2 mRNA observed at calving sug-
gested an increased abundance of lactate available as 
a substrate for gluconeogenesis (Reynolds et al., 2003; 
Weber et al., 2013a; Hammon et al., 2016). Lactate 
originates from increased PDV release and enhanced 
endogenous lactate production by Cori cycling, and 
compensates for decreased availability of propionate 
because of insufficient DMI (Aschenbach et al., 2010; 
Weber et al., 2013a; Hammon et al., 2016). The PCK1 
mRNA expression was elevated after reaching maxi-
mal DMI and was shown to be responsive to rumen 
propionate production, indicating the feed-forward con-
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trol of gluconeogenesis (Weber et al., 2013a; Donkin, 
2016; Hammon et al., 2016). The mRNA abundance 
related to gluconeogenesis in the liver was less affected 
by CLA treatment, but decreased mRNA abundance 
was revealed in cows under EFA treatment during early 
lactation. These findings were not in accord with the 
elevated eGP production, increased plasma glucagon 
concentration and increased glucagon/insulin ratio 
observed in blood plasma during profiling, especially 
in cows treated only with EFA in early lactation, but 
they were associated with lower eGP production in 
EFA+CLA cows after calving. The reasons for these 
partially inconsistent findings between the observed 
gluconeogenic mRNA abundance in the liver and endo-
crine changes are presently not known. Gluconeogenic 
enzymes are regulated at the transcriptional level by 
hormones such as glucagon and insulin but are also 
substrate regulated (Loor, 2010; Donkin, 2016; Ham-
mon et al., 2016). Furthermore, the decreases in mRNA 
abundance in the liver caused by insulin differ among 
the gluconeogenic enzymes during the transition pe-
riod in dairy cows (Weber et al., 2017). The decreased 
mRNA abundance of PC, PCK1, PCK2, G6PC, and 
PCCA during early lactation due to EFA treatment 
might be a consequence of improved insulin sensitivity. 
Previous studies in bulls and cows indicated enhanced 
insulin sensitivity when n-3 FA were supplied (Pires 
and Grummer, 2008; Fortin et al., 2010; Hashemzadeh-
Cigari et al., 2015). The association of hepatic gluco-
neogenic enzyme expression with the measurement of 
eGP and endocrine changes showed the best correspon-
dence under the EFA+CLA treatment. Cows treated 
only with EFA exhibited elevated eGP but low mRNA 
abundance of most of the measured enzymes on d 28 
PP. In cows treated with CLA only, decreased eGP was 
associated with elevated mRNA abundance of PCK1, 
PCK2, G6PC, and PCCA during early lactation. The 
FA treatments applied in the present study clearly af-
fected the regulation of gluconeogenic enzymes at the 
transcription level differentially.
Somatotropic Axis and Hepatic mRNA Abundance  
of the GH-IGF System
The changes in GH, IGF-I, and IGFBP-2 and 
IGFBP-3 in blood plasma around the time of calving 
and during early lactation corresponded to the changes 
in the energy balance in these cows (Vogel et al., 2020). 
The negative energy balance around the time of calving 
and during early lactation is associated with increasing 
concentrations of plasma GH and IGFBP-2 but decreas-
ing plasma IGF-I and IGFBP-3 concentrations (Reist 
et al., 2003; Gross et al., 2011b; Kessler et al., 2013). In 
general, an insufficient energy status or undernutrition 
are connected with an uncoupling of the somatotropic 
axis, indicating increasing GH and decreasing IGF-I 
concentrations as well as a lower IGFBP-3 to IGFBP-2 
ratio in blood plasma (Etherton and Bauman, 1998; 
Renaville et al., 2002; Lucy, 2004). Because the liver 
significantly contributes to the systemic somatotropic 
axis, the negative energy balance during the transition 
period leads to corresponding changes in key factors 
in the somatotropic axis in the liver. Thus, the mRNA 
abundance of GHR1A, IGF1, and IGFBP3 decreased, 
but the IGFB2 mRNA abundance increased (Kobayashi 
et al., 1999; Fenwick et al., 2008; Gross et al., 2011b), 
and the INSR mRNA abundance did not change at 
calving (Gross et al., 2011b; Weber et al., 2017). Simi-
lar responses regarding the abundance of these mRNA 
were determined in the present study, and the findings 
in blood plasma and the liver were consistent with the 
overall concept of nutrition repartitioning at the begin-
ning of lactation (Bauman, 2000; Lucy, 2004; Gross and 
Bruckmaier, 2019).
Cows treated with CLA exhibit an increased plasma 
IGF-I concentration during early lactation (Castañeda-
Gutiérrez et al., 2007; Csillik et al., 2017), which was 
also found in the present study. The improved energy 
status in CLA cows (Vogel et al., 2020) was closely 
related to the increasing IGFBP-3 to IGFBP-2 ratio in 
blood plasma. IGFBP-3 binds most of the IGF-I pres-
ent in blood plasma, whereas IGFBP-2 may support 
the transport of IGF-I from blood plasma into tissue 
(Jones and Clemmons, 1995). The stimulation of the 
somatotropic axis (i.e., elevated IGF-I by decreased GH 
in blood plasma) takes place when plasma glucose and 
insulin concentrations are elevated in dairy cows during 
the transition period (Butler et al., 2003; Rhoads et 
al., 2004). Because the improved energy status in CLA 
cows was associated with an improved glucose and in-
sulin status, the stimulation of the somatotropic axis 
in the present study was closely related to enhanced 
glucose and insulin availability in these cows (McGuire 
et al., 1995; Brameld et al., 1999; Clemmons, 2018). On 
the other hand, the elevated plasma IGFBP-4 concen-
tration observed at the end of the study in CLA-treated 
cows might counteract the increased plasma IGF-I 
concentration because IGFBP-4 has mainly inhibitory 
effects on IGF-I action (Jones and Clemmons, 1995; 
Clemmons, 2018). Plasma GH was less affected by CLA 
treatment, even though previous findings indicated a 
stimulatory effect of CLA on plasma GH (Qin et al., 
2018).
The CLA treatment showed only minor effects on 
stimulating the parameters of the somatotropic axis in 
the liver. The most obvious finding was the inhibition 
Vogel et al.: ESSENTIAL FATTY ACIDS AND CONJUGATED LINOLEIC ACID IN COWS
Journal of Dairy Science Vol. 104 No. 3, 2021
of IGFBP2 by CLA treatment during early lactation, 
which was consistent with the lower plasma IGFBP-2 
concentration observed in CLA-treated cows at the 
end of the study. In addition, there were some minor 
stimulatory effects on GHR1A mRNA but not on IGF1 
mRNA. Although the liver is involved in the release 
of components of the somatotropic axis to the blood 
plasma, the liver is not the only organ that contributes 
to the systemic somatotropic axis, and regulation of the 
hepatic IGF system might occur beyond the transcrip-
tion level. (Thissen et al., 1994; Le Roith et al., 2001).
Changes in plasma concentrations related to the so-
matotropic axis were less affected by EFA treatment. 
These findings corresponded well with the lack of an 
effect of EFA treatment on the energy balance of these 
cows during the transition period (Vogel et al., 2020). 
Therefore, our results differ from earlier studies report-
ing a stimulatory effect of n-3 FA treatment on the 
somatotropic axis in cows (Carriquiry et al., 2009a; 
Dirandeh et al., 2016; Doyle et al., 2019). In the liver, 
there was also no stimulatory effect of EFA treatment 
on mRNA abundance related to the somatotropic axis, 
which again contrasted with the findings of Dirandeh 
et al. (2016). Interestingly, n-3 FA supplementation did 
not affect the stimulation of the hepatic somatotropic 
axis by GH treatment (Carriquiry et al., 2009b). In 
contrast, some inhibitory effects of EFA treatment on 
the mRNA abundance of IGFBP2, IGFBP3, and INSR 
have been observed, but a direct inhibitory effect of n-3 
FA on gene expression related to the somatotropic axis 
in the liver of cows has yet to be demonstrated.
CONCLUSIONS
Our results indicated an improved glucose and insulin 
status along with the stimulation of the somatotropic 
axis in dairy cows treated with CLA, which correspond-
ed well with the improved energy balance during late 
and early lactation in CLA cows (Vogel et al., 2020). In 
contrast, EFA treatment had hardly any influence on 
the endocrine regulation of nutrient partitioning during 
the investigated experimental period, but resulted in 
highest eGP PP in cows treated exclusively with EFA 
and, on the contrary, showed decreased hepatic mRNA 
abundance of genes related to gluconeogenesis. The 
combined EFA+CLA treatment showed very similar re-
sults to the CLA treatment concerning the blood data 
related to the insulin response and the somatotropic 
axis, but the effects on gene expression in the liver 
regarding gluconeogenesis were more consistent to the 
effects of the EFA treatment only. No additive stimula-
tion of the somatotropic axis by the combined EFA and 
CLA treatment was found in the present study.
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